Literature DB >> 31630216

Bisphosphonates and lower mortality risk: when it sounds to be good to be true ….

W D Leslie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31630216     DOI： 10.1007/s00198-019-05157-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  2 in total

Review 1.  Mortality and osteoporotic fractures: is the link causal, and is it modifiable?

Authors:  G G Teng; J R Curtis; K G Saag
Journal:  Clin Exp Rheumatol       Date:  2008 Sep-Oct       Impact factor: 4.473

Review 2.  Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysis.

Authors:  Jing Peng; Yong Liu; Long Chen; Kun Peng; Zhao Xu; Dagang Zhang; Zhou Xiang
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088
  2 in total
  1 in total

Review 1.  Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies.

Authors:  Alexander J Rodríguez; Bo Abrahamsen
Journal:  JBMR Plus       Date:  2021-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.